130
Views
0
CrossRef citations to date
0
Altmetric
Review

Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy

, , &
Pages 35-43 | Published online: 21 Jun 2016

Figures & data

Table 1 Estimated protein expression of TMN biomarkers

Table 2 TMN biomarkers in subcellular locations

Figure 1 Oncolytic viral tropism altered by modification of viral surface proteins.

Notes: The modified virus binds with thyroid cell membrane biomarkers including TSHR, TPO, NIS, CD44, CD133, CAV-1, or Galectin-3. (A) TSH β subunit on the selected oncolytic virus for specific binding TSHR on thyroid cells. (B) Expression of specific antibodies against the thyroid membrane-bound biomarkers. (C) Expression of peptide aptamers that specifically target the TMN biomarkers on the thyroid follicular cells.
Abbreviations: CAV-1, Caveolin-1; NIS, sodium/iodide symporter; CD, cluster of differentiation; LGAL3, galectin-3; TMN, thyroid malignant neoplasm; TPO, thyroid peroxidase; TSHR, thyrotropin receptor.
Figure 1 Oncolytic viral tropism altered by modification of viral surface proteins.